West Pharmaceutical Services Total Long-Term Assets 2010-2024 | WST
West Pharmaceutical Services total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
- West Pharmaceutical Services total long-term assets for the quarter ending September 30, 2024 were $2.125B, a 19.19% increase year-over-year.
- West Pharmaceutical Services total long-term assets for 2023 were $1.893B, a 11.54% increase from 2022.
- West Pharmaceutical Services total long-term assets for 2022 were $1.697B, a 7.98% increase from 2021.
- West Pharmaceutical Services total long-term assets for 2021 were $1.572B, a 10.68% increase from 2020.
West Pharmaceutical Services Annual Total Long-Term Assets
(Millions of US $) |
| 2023 |
$1,893 |
| 2022 |
$1,697 |
| 2021 |
$1,572 |
| 2020 |
$1,420 |
| 2019 |
$1,283 |
| 2018 |
$1,085 |
| 2017 |
$1,119 |
| 2016 |
$1,075 |
| 2015 |
$1,021 |
| 2014 |
$1,011 |
| 2013 |
$1,021 |
| 2012 |
$1,007 |
| 2011 |
$927 |
| 2010 |
$858 |
| 2009 |
$874 |
West Pharmaceutical Services Quarterly Total Long-Term Assets
(Millions of US $) |
| 2024-09-30 |
$2,125 |
| 2024-06-30 |
$2,006 |
| 2024-03-31 |
$1,909 |
| 2023-12-31 |
$1,893 |
| 2023-09-30 |
$1,782 |
| 2023-06-30 |
$1,795 |
| 2023-03-31 |
$1,786 |
| 2022-12-31 |
$1,697 |
| 2022-09-30 |
$1,583 |
| 2022-06-30 |
$1,591 |
| 2022-03-31 |
$1,604 |
| 2021-12-31 |
$1,572 |
| 2021-09-30 |
$1,544 |
| 2021-06-30 |
$1,457 |
| 2021-03-31 |
$1,413 |
| 2020-12-31 |
$1,420 |
| 2020-09-30 |
$1,345 |
| 2020-06-30 |
$1,282 |
| 2020-03-31 |
$1,269 |
| 2019-12-31 |
$1,283 |
| 2019-09-30 |
$1,170 |
| 2019-06-30 |
$1,179 |
| 2019-03-31 |
$1,169 |
| 2018-12-31 |
$1,085 |
| 2018-09-30 |
$1,096 |
| 2018-06-30 |
$1,107 |
| 2018-03-31 |
$1,126 |
| 2017-12-31 |
$1,119 |
| 2017-09-30 |
$1,154 |
| 2017-06-30 |
$1,125 |
| 2017-03-31 |
$1,081 |
| 2016-12-31 |
$1,075 |
| 2016-09-30 |
$1,077 |
| 2016-06-30 |
$1,046 |
| 2016-03-31 |
$1,038 |
| 2015-12-31 |
$1,021 |
| 2015-09-30 |
$986 |
| 2015-06-30 |
$984 |
| 2015-03-31 |
$971 |
| 2014-12-31 |
$1,011 |
| 2014-09-30 |
$994 |
| 2014-06-30 |
$1,019 |
| 2014-03-31 |
$1,022 |
| 2013-12-31 |
$1,021 |
| 2013-09-30 |
$1,021 |
| 2013-06-30 |
$999 |
| 2013-03-31 |
$987 |
| 2012-12-31 |
$1,007 |
| 2012-09-30 |
$970 |
| 2012-06-30 |
$946 |
| 2012-03-31 |
$955 |
| 2011-12-31 |
$927 |
| 2011-09-30 |
$895 |
| 2011-06-30 |
$905 |
| 2011-03-31 |
$885 |
| 2010-12-31 |
$858 |
| 2010-09-30 |
$858 |
| 2010-06-30 |
$818 |
| 2010-03-31 |
$849 |
| 2009-12-31 |
$874 |
| 2009-09-30 |
$865 |
| 2009-06-30 |
$821 |
| 2009-03-31 |
$785 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$23.239B |
$2.950B |
|
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
|
